POLYURETHANE CONDOMS UNDERGOING EXPEDITED REVIEW AT FDA
This article was originally published in The Tan Sheet
POLYURETHANE CONDOMS UNDERGOING EXPEDITED REVIEW AT FDA, Lillian Yin, PhD, director of the Center for Devices and Radiological Health's division of reproductive, abdominal, ear, nose, throat and radiological devices, told a National Institutes of Health workshop on products for contraception and the prevention of sexually transmitted diseases on April 6. Noting that "we have several [510(k) premarket clearance applications] in house," Yin said they will be reviewed according to the date they were received by FDA.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC